DnB Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $281K | Buy |
|
|||||
|
2025
Q2 | $236K | Sell |
|
|||||
|
2025
Q1 | $259K | Buy |
|
|||||
|
2024
Q4 | $261K | Buy |
|
|||||
|
2024
Q3 | $157K | Buy |
|
|||||
|
2024
Q2 | $165K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $291K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $651K | Sell |
|
|||||
|
2022
Q1 | $1.64M | Sell |
|
|||||
|
2021
Q4 | $1.92M | Sell |
|
|||||
|
2021
Q3 | $1.51M | Sell |
|
|||||
|
2021
Q2 | $2.27M | Buy |
|
|||||
|
2021
Q1 | $2.39M | Buy |
|
|||||
|
2020
Q4 | $2.95M | Buy |
|
|||||
|
2020
Q3 | $930K | Buy |
|